Advertisement
DIA
Drug Information Association Logo

Meetings & Training

DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations.

Find Meetings & Training 

Name Start Date Credits Format Region Location
Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients Mar 03, 2015 IACET Online Instruction Global Online
Clinical Investigator: Module 2 - Conducting the Study Mar 03, 2015 ACPE, CME Online Instruction North America Online
Clinical Investigator: Module 1 - Study Preparation and Initiation Mar 03, 2015 ACPE, CME Online Instruction North America Online
Informed Consent Mar 03, 2015 ACPE Online Instruction North America Online
Crisis Management Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Database Management Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Literature Evaluation Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Literature Searching Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Medical Inquiries Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Medical Writing Mar 03, 2015 IACET Online Instruction North America Online
Product Labeling Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Regulatory Issues Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Statistics for Medical Communications Professionals Mar 03, 2015 ACPE, IACET Online Instruction North America Online
Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients Mar 03, 2015 Online Instruction Global Online
US Advertising & Promotion Requirements for Promotional Regulatory Compliance: Fundamentals for Marketing Drugs and Devices Mar 03, 2015 Online Instruction Global Online
US Digital Requirements for Promotional Regulatory Compliance: Fundamentals for Marketing Drugs and Devices Mar 03, 2015 Online Instruction Global Online
European Advertising & Promotion Requirements for Regulatory Compliance: Comparing Fundamentals for Marketing Drugs in 5 Major European Markets (United Kingdom, Italy, Spain, France, and Germany) Mar 03, 2015 Online Instruction Global Online
Generic Drug Labeling Proposed Rule and Safety Updates Mar 03, 2015 Online Instruction Global Online
Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization Mar 03, 2015 Online Instruction Global Online
GVP Module IX Compliant Signal Management Systems in Pharmacovigilance: A Tale of Two Experiences Mar 03, 2015 Online Instruction Global Online
The Role of the Clinical Data Manager Mar 03, 2015 Online Instruction Global Online
Implementation of the FDASIA Patient Provisions Mar 03, 2015 Online Instruction Global Online
Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Mar 03, 2015 Online Instruction Global Online
Variations in the European Union: CMC/Quality Changes Mar 03, 2015 Online Instruction Global Online
Proarrhythmia Mar 03, 2015 Online Instruction Global Online
Facets of Drug-Induced Kidney Injury and Regulatory Perspective Mar 03, 2015 Online Instruction Global Online
Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Mar 03, 2015 Online Instruction Global Online
Pharmacovigilance and Risk Management: Patient Perspective Mar 03, 2015 Online Instruction Global Online
Drug Safety Regulatory Requirements Mar 03, 2015 ACPE, IACET Online Instruction Global Online
Premarketing Clinical Trial Safety Mar 03, 2015 ACPE, IACET Online Instruction Global Online
Postmarketing Safety Management Mar 03, 2015 ACPE, IACET Online Instruction Global Online
Basics of Signal Detection and Pharmacoepidemiology Mar 03, 2015 ACPE, IACET Online Instruction Global Online
Safety Audits and Inspections Mar 03, 2015 ACPE, IACET Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Mar 03, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Mar 03, 2015 Online Instruction Global Online
Pharmacovigilance and Global Harmonization Updates Mar 03, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Mar 03, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Mar 03, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Mar 03, 2015 Online Instruction Global Online
Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies Mar 03, 2015 Online Instruction Global Online
Negotiation and Influence Mar 03, 2015 Online Instruction Global Online
Introduction to Drug Safety Mar 03, 2015 ACPE, IACET Online Instruction Global Online
How to Prepare for a Safety Inspection Mar 03, 2015 Online Instruction Global Online
Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Mar 03, 2015 Online Instruction Global Online
Clinical Statistics for Nonstatisticians Mar 03, 2015 Online Instruction Global Online
Advanced Clinical Statistics for Nonstatisticians Mar 03, 2015 Online Instruction Global Online
Development of a Clinical Study Report Mar 03, 2015 Online Instruction Global Online
Art of Writing a Clinical Overview Mar 03, 2015 Online Instruction Global Online
Introductory Principles and Application of Risk Management within Clinical Operations Mar 03, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Mar 03, 2015 Online Instruction Global Online
Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate Mar 03, 2015 Online Instruction Global Online
Disruptive Innovation in Medical Information Mar 03, 2015 Online Instruction Global Online
A Tour of FDA Mar 03, 2015 Online Instruction Global Online
A Tour of Health Canada Mar 03, 2015 Online Instruction Global Online
A Tour of Health Europe Mar 03, 2015 Online Instruction Global Online
Aspects of Regulatory History Mar 03, 2015 Online Instruction Global Online
Bioresearch Monitoring Program (BIMO): Introduction Mar 03, 2015 Online Instruction Global Online
The Clinical Development Process: Investigational Product, Plan, and Data Management Mar 03, 2015 Online Instruction Global Online
Ethical Review Boards Mar 03, 2015 Online Instruction Global Online
Ethics as the Foundation to Clinical Research Mar 03, 2015 Online Instruction Global Online
Awareness of FDA Inspections for Pharmaceutical Manufacturers Mar 03, 2015 Online Instruction Global Online
Biotechnology: An Overview of Compliance Considerations Mar 03, 2015 Online Instruction Global Online
Change Control Mar 03, 2015 Online Instruction Global Online
Clinical Trial Audits and Consequences of Non-Compliance Mar 03, 2015 Online Instruction Global Online
Computerized Systems Inspections in the Medical Device Industry Mar 03, 2015 Online Instruction Global Online
European Union Clinical Trials Directive Mar 03, 2015 Online Instruction Global Online
GMP Principals of SOPs Mar 03, 2015 Online Instruction Global Online
GMP Updates - Enforcement Changes at the New FDA Mar 03, 2015 Online Instruction Global Online
GMPs for API Bulk Manufacturers Mar 03, 2015 Online Instruction Global Online
Good Clinical Practices (GCPs) for New Product Investigations Mar 03, 2015 Online Instruction Global Online
Good Laboratory Practices (GLPs) Mar 03, 2015 Online Instruction Global Online
GxPs Mar 03, 2015 Online Instruction Global Online
HIPAA - The Impact on Clinical Research Mar 03, 2015 Online Instruction Global Online
Introduction to GMPs Mar 03, 2015 Online Instruction Global Online
Investigational Product Development Mar 03, 2015 Online Instruction Global Online
ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Mar 03, 2015 Online Instruction Global Online
Key Concepts of Process Validation Mar 03, 2015 Online Instruction Global Online
Laboratory Specimens for Clinical Research Mar 03, 2015 Online Instruction Global Online
Medical Device Safety Reporting Mar 03, 2015 Online Instruction Global Online
Orientation to GMP Compliance Mar 03, 2015 Online Instruction Global Online
Overview of the Clinical Research Process Mar 03, 2015 Online Instruction Global Online
Part 11: Electronic Records and Signatures - Application Mar 03, 2015 Online Instruction Global Online
Part 11: Electronic Records; Electronic Signatures Mar 03, 2015 Online Instruction Global Online
Principles of Good Documentation Mar 03, 2015 Online Instruction Global Online
Protection of Human Subjects in Clinical Trials Mar 03, 2015 Online Instruction Global Online
Selecting and Managing Clinical Contract Research Organizations (CROs) Mar 03, 2015 Online Instruction Global Online
Understanding Post-Approval Changes Mar 03, 2015 Online Instruction Global Online
Computerized Systems Inspections in the Pharmaceutical Industry Mar 03, 2015 Online Instruction Global Online
Basics of the PhRMA Code Mar 03, 2015 Online Instruction Global Online
Basics of AdvaMed Code Mar 03, 2015 Online Instruction Global Online
Eucomed Guidelines on Interactions with Healthcare Professionals Mar 03, 2015 Online Instruction Global Online
Introduction to Medical Device Health Care Compliance Mar 03, 2015 Online Instruction Global Online
Foreign Corrupt Practices Act Mar 03, 2015 Online Instruction Global Online
Global Anti-bribery Mar 03, 2015 Online Instruction Global Online
Variations to Marketing Authorisation in Europe Mar 03, 2015 Online Instruction Global Online
Registration of Monoclonal Antibodies Mar 03, 2015 Online Instruction Global Online
How to Gain Approval to Market a Generic Medicinal Product in the USA Mar 03, 2015 Online Instruction Global Online
Pharmacokinetics and Pharmacodynamics in Drug Registration Mar 03, 2015 Online Instruction Global Online
Complimentary Quintiles/DIA Webinar - Giving Your Study The Right Start Toward Success Through Optimal Country and Site Selection Mar 03, 2015 Online Instruction Global Online
Implementing Risk-Based Monitoring: Practical Approaches Mar 03, 2015 Online Instruction Global Online
Complimentary - Innovative Strategies for Developing Safer Cancer Therapies Mar 03, 2015 Online Instruction Global Online
Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application Mar 03, 2015 Online Instruction Global Online
Fundamentals of Project Management for Nonproject Managers Mar 03, 2015 Online Instruction Global Online
Planning and Managing Your Projects Mar 03, 2015 Online Instruction Global Online
Team Building and Development Mar 03, 2015 Online Instruction Global Online
Pricing, Economic, Reimbursement, Market Share (PERMS) Strategy: An Interactive Holistic Approach in Rare Diseases Mar 03, 2015 Online Instruction Global Online
Introduction to the European Union Institutions and Regulatory Authority Mar 03, 2015 Online Instruction Global Online
Introduction to US Institutions and Regulatory Authority (FDA) Mar 03, 2015 Online Instruction Global Online
Introduction to Japanese Institutions and Regulatory Authorities Mar 03, 2015 Online Instruction Global Online
Overview of the CTD and eCTD Mar 03, 2015 Online Instruction Global Online
Introduction to the International Conference on Harmonisation (ICH) Mar 03, 2015 Online Instruction Global Online
The Regulatory Development of a Drug Mar 03, 2015 Online Instruction Global Online
Basics of Clinical Trials Mar 03, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Centralized Procedure Mar 03, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Mutual Recognition Procedure Mar 03, 2015 Online Instruction Global Online
How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Mar 03, 2015 Online Instruction Global Online
How to Register a New Drug in the USA Mar 03, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Decentralized Procedure Mar 03, 2015 Online Instruction Global Online
Access to Unapproved Drugs through Compassionate Use Mar 03, 2015 Online Instruction Global Online
Regulatory Requirements for the Conduct of Clinical Trials in Europe Mar 03, 2015 Online Instruction Global Online
Orphan Drugs in the USA, European Union, and Japan Mar 03, 2015 Online Instruction Global Online
Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Mar 03, 2015 Online Instruction Global Online
Meeting Opportunities with Regulatory Agencies Mar 03, 2015 Online Instruction Global Online
Complementary - How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Mar 03, 2015 Online Instruction Global Online
Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask Mar 03, 2015 Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Mar 03, 2015 Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Mar 03, 2015 Online Instruction Global Online
Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Mar 03, 2015 Online Instruction Global Online
Adverse Event Reporting Requirements: IND and Postmarketing Mar 03, 2015 Online Instruction Global Online
Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Mar 03, 2015 Online Instruction Global Online
The Future of Personalized Medicine and Companion Diagnostics Mar 03, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Mar 03, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Mar 03, 2015 Online Instruction Global Online
Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Mar 03, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview Mar 03, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Mar 03, 2015 Online Instruction Global Online
Basics of the IND Mar 03, 2015 Online Instruction Global Online
Basics of the NDA Mar 03, 2015 Online Instruction Global Online
Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Mar 03, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Mar 03, 2015 Online Instruction Global Online
Supplements and Other Changes to an Approved Application Mar 03, 2015 Online Instruction Global Online
Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Mar 03, 2015 Online Instruction Global Online
Pricing, Economic, Reimbursement, Market Share (PERMS) Strategy: An Interactive Holistic Approach in Rare Diseases Mar 05, 2015 IACET Online Instruction Global Online
Preparing a Clinical Trial Budget Mar 10, 2015 IACET, PMI Online Instruction Global Online
Complimentary Webinar - How to Cut Clinical Trial Timelines in Half Mar 12, 2015 Online Instruction Global Online
Expert Reactor Panel: IOM Report on Sharing Clinical Trial Data Mar 13, 2015 Online Instruction Global Online
Regulatory Affairs: The IND, NDA, and Postmarketing Mar 15, 2015 IACET In-Person Instruction North America Irvine, CA, United States
Core Curriculum Mar 15, 2015 In-Person Instruction North America Glendale, AZ, United States
AMWA Workshop - Fundamentals of Ethics and Practical Applications (RR) [4020] Mar 15, 2015 In-Person Instruction North America
Medical Communications: Compliance in 2015 Mar 16, 2015 ACPE, IACET, RN In-Person Instruction North America
Medical Science Liaison Tutorial – The Basics for Success Mar 16, 2015 In-Person Instruction North America
AMWA Workshop – Reporting Correlation and Regression Analyses (RR/G/SG) [4011] Mar 16, 2015 In-Person Instruction North America
Medical & Scientific Communications 2015 Annual Forum Mar 16, 2015 Meetings North America Glendale, AZ, United States
Premarketing Clinical Safety and Pharmacovigilance Mar 23, 2015 IACET In-Person Instruction North America Washington, DC, United States
Preparing for a US FDA Advisory Committee Meeting Mar 30, 2015 IACET In-Person Instruction North America Washington, DC, United States
GVP Module IX Compliant Signal Management Systems in Pharmacovigilance: A Tale of Two Experiences Apr 02, 2015 ACPE, IACET Online Instruction Global Online
Complimentary Webinar - How Revolutionary Machine Learning Advancements Improve Healthcare Research Productivity, Reduce Complexity, and Drive Discovery of Valuable Insights and Relationships across Disparate Content Repositories Apr 08, 2015 Online Instruction Global Online
CMC Workshop 2015 Apr 13, 2015 ACPE, IACET Meetings North America Bethesda, MD, United States
Regulatory Affairs for Biologics Apr 14, 2015 IACET In-Person Instruction North America Bethesda, MD, United States
Tutorial 1: Statisticians as Leaders Apr 19, 2015 IACET In-Person Instruction North America North Bethesda, MD, United States
Tutorial 2: Propensity Score Methodology Application to Observational Comparative Studies in Regulatory Settings Apr 19, 2015 IACET In-Person Instruction North America North Bethesda, MD, United States
Tutorial 3: Subgroup Analysis in Clinical Trials Apr 19, 2015 IACET In-Person Instruction North America North Bethesda, MD, United States
Tutorial 4: Dose Finding in Drug Development: Methods and Implementation Apr 19, 2015 IACET In-Person Instruction North America North Bethesda, MD, United States
Advanced Signal Detection - Tools, Triage, Evaluation, and Escalation Apr 20, 2015 In-Person Instruction North America Washington, DC, United States
DIA/FDA Statistics 2015 Forum Apr 20, 2015 IACET Meetings North America North Bethesda, MD, United States
Biosimilar Development: Strategies and Regulatory Requirements for Global Market Entry Apr 27, 2015 In-Person Instruction North America Washington, DC, United States
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Apr 29, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
Basics of the IND Phase May 04, 2015 IACET Online Instruction Global Online
Oversight of Clinical Monitoring: Trends and Strategies May 05, 2015 IACET Online Instruction Global Online
eRegulatory and Intelligence Annual Conference May 11, 2015 Meetings North America Philadelphia, PA, United States
Electronic Submissions: The Next Era of Electronic Submissions May 14, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
Basics of the NDA Phase May 18, 2015 IACET Online Instruction Global Online
DIA Canadian Pharmacovigilance & Risk Management Meeting May 21, 2015 Meetings North America Toronto, ON, Canada
How to Prepare for a Safety Inspection Jun 01, 2015 IACET Online Instruction Global Online
#20: The Sunshine Act: Understanding the Essentials of Compliance Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#21: Leadership: How to Organize and Lead People in a Work Group Jun 14, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
#22: Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions, and Regulatory Document Writing Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#23: How to Prepare for an FDA Inspection Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#24: Pharmacogenomics and Companion Diagnostics: The Future of Clinical Trials, New Product Development and the Practice of Medicine Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#25: Signal Detection: Identifying and Managing Safety Signals Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
DIA 2015 51st Annual Meeting: Develop. Innovate. Advance. Jun 14, 2015 Meetings North America Washington, DC, United States
#40: Analysis of Safety Data from Clinical Trials Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#41: Quality Oversight of CROs-Clinical Vendors Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#42: Fundamentals of ANDA Submissions and FDA Expectations Under GDUFA Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#43: Clinical Statistics for Nonstatisticians Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#44: Risk Management and Safety Communication Strategies Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#45: The Good Pharmacovigiliance Practices in the EU: Global Applications Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#30: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Affecting Pharmaceutical Development Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#31: Preparing for a US FDA Advisory Committee Meeting Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#32: Influencing Culture, Avoiding Bureaucracy, and Encouraging Innovation Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#33: Large-Scale Regulatory Functional Outsourcing: Emerging Trends, Challenges, and Decision Criteria Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#34: Preparation of Risk Evaluation and Mitigation Strategies Assessment Reports Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#35: Ethical Issues in Clinical Trials Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
Adverse Event Reporting Requirements: IND and Post-marketing Jul 13, 2015 Online Instruction Global Online
Interactions with the FDA during IND/NDA Phases Jul 16, 2015 Online Instruction Global Online
Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America and Other Emerging Markets Aug 03, 2015 In-Person Instruction North America Washington, DC, United States
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Aug 10, 2015 ACPE, IACET In-Person Instruction North America Boston, MA, United States
Development of a Clinical Study Report Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
Regulatory Affairs: The IND, NDA, and Postmarketing Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
Clinical Project Management Aug 24, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
New Drug Product Development and Life Cycle Management Aug 26, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
Overview of Drug Development in Japan Sep 02, 2015 Online Instruction Global Online
DIA/FDA Oligonucleotide-based Therapeutic Conference 2015 Sep 09, 2015 Meetings North America Washington, DC, United States
Adaptive Design in Clinical Trials: When and How to Apply Sep 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
Patient Engagement in Benefit-Risk Assessment throughout the Life Cycle of Medical Products Sep 17, 2015 Meetings North America North Bethesda, MD, United States
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Sep 28, 2015 ACPE, IACET In-Person Instruction North America Toronto, ON, Canada
Clinical Statistics for Nonstatisticians Sep 28, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
Introduction to Signal Detection and Data Mining Oct 05, 2015 IACET Online Instruction Global Online
Risk Management and Safety Communication Oct 26, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
Postmarketing Drug Safety & Pharmacovigilance Nov 09, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States
Regulatory Affairs: The IND, NDA, and Postmarketing Nov 09, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
Navigating Chemistry, Manufacturing and Controls Through the Drug Development Process Nov 09, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
Advanced Clinical Statistics for NonStatisticians Nov 11, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States